alexa F Nicholas Franano |
ISSN: 2329-6607

Cardiovascular Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

F Nicholas Franano

Research and Development
Proteon Therapeutics, Inc.
Waltham, Massachusetts, USA
Biography

F. Nicholas Franano, MD, is a physician, scientist, inventor and entrepreneur. He is President and CEO of Flow Forward Medical, a company developing the Arteriovenous Fistula Eligibility (AFE) System™, a medical device designed to rapidly establish high-quality vascular access sites for hemodialysis patients. Dr. Franano also serves as President and CEO of Metactive Medical, a company developing novel, endovascular medical devices for the treatment of peripheral vascular and neurovascular diseases.

Research Interest

Cardiovascular diseases, interventional radiology, peripheral vascular and neurovascular diseases, Congestive Heart Failure

Publications

Recombinant Human Elastase Treatment of Cephalic Veins

Marco D Wong, Karen Bingham, Emma Moss, J Donald Warn, Igor Smirnov, Kimberly S Bland, Barry Starcher, F Nicholas Franano and Steven K Burke

Research Article: Cardiovasc Pharm Open Access 2016, 5: 178

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords